We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · May 23, 2022

Impact of Biologics on HRQoL in Patients With Ankylosing Spondylitis

Seminars in Arthritis and Rheumatism


Additional Info

Seminars in Arthritis and Rheumatism
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials
Semin. Arthritis Rheum. 2022 Mar 19;54(2022)151996, A Ho, I Younis, QA Le

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading